Acasti Pharma Inc. (ACST)

1 member of Congress has disclosed 2 trades in Acasti Pharma Inc. (ACST) via STOCK Act filings. The most recent disclosure was a purchase by Mark E. Green on 16 March 2021. Aggregate disclosed activity totals roughly $16K in purchases (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for ACST
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for ACST

2 transactions
Compliance: 50%
Mark E. Green16 Mar 202128 Mar 2021PurchaseStock$1,001 - $15,000N/A
Mark E. Green16 Mar 202130 Apr 2022PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$34.17M

Volume

27.68K

Beta

1.52

P/E Ratio

-2.36

Fundamentals

EPS

$-1.43

Div. Yield

-

Open

$3.43

Day Range

$3.20 – $3.45

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
CA
CEO
Prashant Kohli
IPO Date
2012-02-07
Website
www.gracetx.com

Acasti Pharma Inc. operates as a biopharmaceutical firm, concentrating its efforts on developing and marketing pharmaceutical solutions specifically for cardiovascular conditions. The company is currently exploring potential strategic alliances to fu...

Earnings

Recent Quarters

Q3 202411 Nov
EPS$-0.19
Beat 57.8%
Q2 20249 Aug
EPS$-0.24
Beat 14.3%
Q1 202421 Jun
EPS$-0.18
Beat 48.6%
Q4 202312 Feb
EPS$-0.21
Beat 30.0%
Q3 202313 Nov
EPS$-0.22
Beat 24.1%
Q2 202311 Aug
EPS$-0.54
Miss 500.0%
Q1 202323 Jun
EPS$-3.90
Miss 400.0%
Q4 202214 Feb
EPS$-0.54
Miss 260.0%
Q3 202214 Nov
EPS$-0.66
Q2 202211 Aug
EPS$-0.60
Q1 202221 Jun
EPS$-0.24
Miss 84.6%
Q4 202114 Feb
EPS$-0.54
Miss 12.5%
Q3 202110 Nov
EPS$0.18
Q2 202112 Aug
EPS$-0.48
Q1 202122 Jun
EPS$-1.44
Q4 20209 Feb
EPS$-0.96
Miss 134.2%
Q3 202016 Nov
EPS$-2.40
Beat 28.6%
Q2 202013 Aug
EPS$-2.40
Beat 28.6%
Q1 202029 Jun
EPS$-2.40
Beat 44.4%
Q4 201914 Feb
EPS$-6.72
Miss 552.4%
Q3 201913 Nov
EPS$-2.88
Beat 25.0%
Q2 201914 Aug
EPS$-5.28
Beat 8.3%
Q1 201926 Jun
EPS$-8.16
Miss 54.5%
Q4 201814 Feb
EPS$-2.40
Beat 37.5%
Q3 201814 Nov
EPS$-9.12
Beat 9.5%
Q2 201814 Aug
EPS$-1.84
Beat 14.8%
Q1 201827 Jun
EPS$-2.56
Miss 20.2%
Q4 201713 Feb
EPS$-0.40
Beat 87.2%
Q3 201713 Nov
EPS$-11.84
Q2 201714 Aug
EPS$-6.72
Q1 20176 Jun
EPS$-8.16
Q4 201612 Jan
EPS$-8.16
Q3 201611 Oct
EPS$-8.16
Q2 201611 Jul
EPS$-11.04
Q1 201625 May
EPS$-6.24
Q4 201512 Jan
EPS$-7.68
Q3 201514 Oct
EPS$-4.80
Q2 201513 Jul
EPS$-4.80
Q1 201527 May
EPS$-9.60
Q4 201413 Jan
EPS$14.40
Beat 200.0%
Q3 201414 Oct
EPS$-14.40
Miss 4700.0%
Q2 201415 Jul
EPS$4.80
Beat 133.3%
Q1 201421 May
EPS$-0.20
Beat 33.3%
Q1 201321 May
EPS$-11.58

No dividend data available for this stock.

Stock Splits

Split History

10 Jul 2023Reverse Split
Ratio1:6
31 Aug 2021Reverse Split
Ratio1:8
15 Oct 2015Reverse Split
Ratio1:10

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ACST

Which members of Congress have traded ACST?
1 member of Congress has disclosed 2 trade in Acasti Pharma Inc. (ACST) under the STOCK Act: Mark E. Green.
When was ACST most recently disclosed by Congress?
The most recent ACST disclosure was a purchase by Mark E. Green on 16 March 2021.
What is the total disclosed congressional trading volume for ACST?
Members of Congress have disclosed approximately $16K in ACST purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in ACST?
This ACST page updates as soon as new STOCK Act disclosures are filed for Acasti Pharma Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.